Acetylfentanyl

Last updated
Acetylfentanyl
Acetylfentanyl.svg
Acetylfentanyl 3D BS.png
Clinical data
Other namesAcetyl fentanyl
Routes of
administration
oral, iv, im, insuflation
ATC code
  • none
Legal status
Legal status
  • AU:Illegal
  • BR: Class F1 (Prohibited narcotics)
  • CA: Schedule I [1]
  • DE: Anlage II (Authorized trade only, not prescriptible)
  • UK: Class A
  • US: Schedule I [2]
  • Illegal in China, Cyprus, Estonia, Finland, Ireland, Latvia, Lithuania, Norway, Poland, Sweden and Switzerland [3]
Identifiers
  • N-(1-Phenethylpiperidin-4-yl)-N-phenylacetamide
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
CompTox Dashboard (EPA)
ECHA InfoCard 100.169.973 OOjs UI icon edit-ltr-progressive.svg
Chemical and physical data
Formula C21H26N2O
Molar mass 322.452 g·mol−1
3D model (JSmol)
  • CC(N(C1=CC=CC=C1)C2CCN(CCC3=CC=CC=C3)CC2)=O
  • InChI=1S/C21H26N2O/c1-18(24)23(20-10-6-3-7-11-20)21-13-16-22(17-14-21)15-12-19-8-4-2-5-9-19/h2-11,21H,12-17H2,1H3
  • Key:FYIUUQUPOKIKNI-UHFFFAOYSA-N

Acetylfentanyl (acetyl fentanyl) is an opioid analgesic drug that is an analog of fentanyl. [4] Studies have estimated acetylfentanyl to be 15 times more potent than morphine, [5] [6] which would mean that despite being somewhat weaker than fentanyl, it is nevertheless still several times stronger than pure heroin. It has never been licensed for medical use and instead has only been sold as a designer drug. Acetylfentanyl was discovered at the same time as fentanyl itself and had only rarely been encountered on the illicit market in the late 1980s. However, in 2013, Canadian police seized 3 kilograms of acetylfentanyl. [7] As a μ-opioid receptor agonist, acetylfentanyl may serve as a direct substitute for heroin or other opioids. Common side effects of fentanyl analogs are similar to those of fentanyl itself, which include itching, nausea and potentially serious respiratory depression, which can be life-threatening. Fentanyl analogs have killed hundreds of people throughout Europe and the former Soviet republics since the most recent resurgence in use began in Estonia in the early 2000s, and novel derivatives continue to appear. [8] [9] [10]

Contents

Deaths

Europe

Acetylfentanyl has been analytically confirmed in 32 fatalities in four European member states between 2013 and August 2015, Germany (2), Poland (1), Sweden (27) and the United Kingdom (2). [3]

Russia

Twelve deaths have been associated with acetylfentanyl in Russia since 2012. [3] [11]

United States

The Centers for Disease Control and Prevention (CDC) issued a health alert to report that between March 2013 and May 2013, 14 overdose deaths related to injected acetylfentanyl had occurred among intravenous drug users (ages between 19 and 57 years) in Rhode Island. After confirming five overdoses in one county, including a fatality, Pennsylvania asked coroners and medical examiners across the state to screen for acetylfentanyl. As a result of this investigation, Pennsylvania confirmed at least one acetylfentanyl overdose death and attributed at least 50 fatalities to either fentanyl or acetylfentanyl during the first half of 2013. [12] [13] In July 2015, the DEA informed about 52 confirmed fatalities involving acetylfentanyl in the United States between 2013 and 2015. [14]

Japan

One fatal poisoning caused by intravenous injection of a "bath salt" product containing acetylfentanyl and 4'-Methoxy-α-pyrrolidinopentiophenone (or 4-MeO-α-PVP, a substituted cathinone) has been reported in 2016. [15]

Canada

As an analog of fentanyl, acetylfentanyl is a Schedule I controlled drug. [1]

China

As of October 2015 acetylfentanyl is a controlled substance in China. [16]

United States

Acetylfentanyl is a Schedule I controlled substance as of May 2015. [17]

Switzerland

As of March 2023, acetylfentanyl is a controlled substance in Switzerland. [18]

United Kingdom

Acetylfentanyl was made a class A drug as an analogue of fentanyl in 1986. [19]

Overdose

Acetylfentanyl overdosage has been reported to closely resemble heroin overdosage clinically. Additionally, while naloxone (Narcan) is effective in treating acetylfentanyl overdose, larger than normal doses of the antidote may be required. [5]

Detection in body fluids

Acetylfentanyl may be quantitated in blood, plasma or urine by liquid chromatography-mass spectrometry to confirm a diagnosis of poisoning in hospitalized patients or to provide evidence in a medicolegal death investigation. Postmortem peripheral blood acetylfentanyl concentrations have been in a range of 89–945 μg/L in victims of acute overdosage. [20] [21]

See also

Related Research Articles

<span class="mw-page-title-main">Fentanyl</span> Opioid medication

Fentanyl is a potent synthetic piperidine opioid primarily used as an analgesic. It is 20 to 40 times more potent than heroin and 100 times more potent than morphine; its primary clinical utility is in pain management for cancer patients and those recovering from painful surgeries. Fentanyl is also used as a sedative. Depending on the method of delivery, fentanyl can be very fast acting and ingesting a relatively small quantity can cause overdose. Fentanyl works by activating μ-opioid receptors. Fentanyl is sold under the brand names Actiq, Duragesic and Sublimaze, among others.

α-Methylfentanyl Opioid analgesic

α-Methylfentanyl an opioid analgesic that is an analog of fentanyl. It is sometimes sold as "China White".

<span class="mw-page-title-main">Phenaridine</span> Opioid analgesic

Phenaridine (2,5-dimethylfentanyl) is an opioid analgesic that is an analogue of fentanyl. It was developed in 1972, and is used for surgical anasthesia.

<span class="mw-page-title-main">Ocfentanil</span> Synthetic opioid

Ocfentanil is a potent synthetic opioid structurally related to fentanyl that was developed in the early 1990s as one of a series of potent naloxone-reversible opioids in an attempt to obtain an opioid that had better therapeutic indices in terms of cardiovascular effects and respiratory depression as compared to fentanyl. Ocfentanil was never developed for medical use despite reasonable results in human clinical trials, but subsequently started to be sold as a designer drug starting in around 2013.

<span class="mw-page-title-main">Butyrfentanyl</span> Synthetic opioid analgesic

Butyrfentanyl or butyrylfentanyl is a potent short-acting synthetic opioid analgesic drug. It is an analog of fentanyl with around one quarter of its potency. One of the first mentions of this drug can be found in document written by The College on Problem of Drug Dependence, where it is mentioned as N-butyramide fentanyl analog. This document also states that the article describing its clinical effects was published in 1987. It is an agonist for the μ-opioid receptors.

<span class="mw-page-title-main">Furanylfentanyl</span> Opioid analgesic

Furanylfentanyl (Fu-F) is an opioid analgesic that is an analog of fentanyl and has been sold as a designer drug. It has an ED50 value of 0.02 mg/kg in mice. This makes it approximately one fifth as potent as fentanyl.

<span class="mw-page-title-main">3-Methylbutyrfentanyl</span> Opioid analgesic

3-Methylbutyrfentanyl (3-MBF) is an opioid analgesic that is an analog of butyrfentanyl.

<span class="mw-page-title-main">4-Fluorobutyrfentanyl</span> Opioid analgesic

4-Fluorobutyrylfentanyl (also known as 4-FBF and p-FBF or para-fluorobutyrylfentanyl) is an opioid analgesic that is an analog of butyrfentanyl and has been sold online as a designer drug. It is closely related to 4-fluorofentanyl, which has an EC50 value of 4.2 nM for the human μ-opioid receptor.

<span class="mw-page-title-main">4-Methoxybutyrfentanyl</span> Opioid analgesic

4-Methoxybutyrfentanyl is an opioid analgesic that is an analog of butyrfentanyl and has been sold online as a designer drug.

<span class="mw-page-title-main">Acrylfentanyl</span> Opioid analgesic

Acrylfentanyl (also known as acryloylfentanyl) is a highly potent opioid analgesic that is an analog of fentanyl and has been sold online as a designer drug. In animal studies the IC50 (the half maximal inhibitory concentration for acrylfentanyl to displace naloxone) is 1.4 nM, being slightly more potent than fentanyl itself (1.6 nM) as well as having a longer duration of action.

<span class="mw-page-title-main">Methoxyacetylfentanyl</span> Opioid analgesic

Methoxyacetylfentanyl, commonly known as MAF is an opioid analgesic that is an analog of fentanyl and has been sold online as a designer drug.

<span class="mw-page-title-main">Tetrahydrofuranylfentanyl</span> Opioid analgesic

Tetrahydrofuranylfentanyl is an opioid analgesic that is an analog of fentanyl and has been sold online as a designer drug, first appearing in Europe in late 2016.

<span class="mw-page-title-main">Cyclopentylfentanyl</span> Opioid analgesic

Cyclopentylfentanyl is an opioid analgesic that is an analog of fentanyl and has been sold online as a designer drug, mainly in Sweden and other Scandinavian countries.

<span class="mw-page-title-main">4-Fluoroisobutyrfentanyl</span> Chemical compound

4-Fluoroisobutyrylfentanyl (also known as 4-FIBF and p-FIBF) is an opioid analgesic that is an analog of butyrfentanyl and structural isomer of 4-Fluorobutyrfentanyl and has been sold online as a designer drug. It is closely related to 4-fluorofentanyl, which has an EC50 value of 4.2 nM for the human μ-opioid receptor. 4-fluoroisobutyrylfentanyl is a highly selective μ-opioid receptor agonist whose analgesic potency is almost ten times of that reported for morphine.

<span class="mw-page-title-main">4-Chloroisobutyrylfentanyl</span> Opioid analgesic

4-Chloroisobutyrylfentanyl is an opioid analgesic that is an analog of fentanyl, and has been sold online as a designer drug.

<span class="mw-page-title-main">Butyrylnorfentanyl</span> Synthetic opioid analgesic metabolite

Butyrnorfentanyl or butyrylnorfentanyl is an inactive synthetic opioid analgesic drug precursor. It is an analog of fentanyl.

Despropionyl-<i>p</i>-fluorofentanyl Synthetic opioid analgesic precursor

Despropionyl-p-fluorofentanyl is an inactive synthetic opioid analgesic drug precursor to 4-fluorofentanyl. It is an analog of fentanyl.

<span class="mw-page-title-main">Furanyl norfentanyl</span> Synthetic opioid analgesic metabolite

Furanylnorfentanyl is an inactive synthetic opioid analgesic drug precursor. It is an analog of fentanyl.

<span class="mw-page-title-main">Norfentanyl</span> Synthetic opioid analgesic metabolite and precursor

Norfentanyl is an inactive synthetic opioid analgesic drug precursor. It is an analog and metabolite of fentanyl with the removal of the phenethyl moiety from fentanyl chemical structure.

<span class="mw-page-title-main">Remifentanilic acid</span> Inactive metabolite of remifentanil

Remifentanilic acid is a metabolite of the potent short-acting synthetic opioid analgesic drug remifentanil. It is an analog of fentanyl and remifentanil, but is not active as an opioid in its own right.

References

  1. 1 2 "Controlled Drugs and Substances Act". IsomerDesign.
  2. "Two Charged With Witness Tampering in Joint Woonsocket Police, DEA Investigation". The United States Attorney's Office: District of Rhode Island. US Department of Justice. 6 June 2013.
  3. 1 2 3 European Monitoring Centre for Drugs Drug Addiction; European Police Office (June 2016). EMCDDA–Europol Joint Report on acetylfentanyl. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). doi:10.2810/890694. ISBN   9789291689163.
  4. Helander A, Bäckberg M, Beck O (20 April 2016). "Intoxications involving the fentanyl analogs acetylfentanyl, 4-methoxybutyrfentanyl and furanylfentanyl: results from the Swedish STRIDA project". Clinical Toxicology. 54 (4): 324–32. doi:10.3109/15563650.2016.1139715. PMID   26850293. S2CID   41668288.
  5. 1 2 Higashikawa Y, Suzuki S (June 2008). "Studies on 1-(2-phenethyl)-4-(N-propionylanilino)piperidine (fentanyl) and its related compounds. VI. Structure-analgesic activity relationship for fentanyl, methyl-substituted fentanyls and other analogues". Forensic Toxicology. 26 (1): 1–5. doi:10.1007/s11419-007-0039-1. ISSN   1860-8965. S2CID   22092512.
  6. Aceto MD, Bowman ER, Harris LS, May EL (1989). "Dependence studies on new compounds in the rhesus monkey, rat and mouse (1989)" (PDF). NIDA Research Monograph. 95: 578–631. PMID   2641054. Archived from the original (PDF) on 2016-12-22. Retrieved 2016-08-26.
  7. "Extremely potent painkiller hits Montreal black market". CBS News. 13 May 2013.
  8. Mounteney J, Giraudon I, Denissov G, Griffiths P (July 2015). "Fentanyls: Are we missing the signs? Highly potent and on the rise in Europe". The International Journal on Drug Policy. 26 (7): 626–31. doi:10.1016/j.drugpo.2015.04.003. PMID   25976511.
  9. Ruangyuttikarn W, Law MY, Rollins DE, Moody DE (May–June 1990). "Detection of fentanyl and its analogs by enzyme-linked immunosorbent assay". Journal of Analytical Toxicology. 14 (3): 160–4. doi:10.1093/jat/14.3.160. PMID   2374405.
  10. Kroll D (29 August 2013). "CDC Issues Alert On Deadly New Designer Drug, Acetyl Fentanyl". Forbes .
  11. Melent'ev AB, Kataev SS, Dvorskaya ON (February 2015). "Identification and analytical properties of acetyl fentanyl metabolites". Journal of Analytical Chemistry. 70 (2): 240–248. doi:10.1134/S1061934815020124. ISSN   1061-9348. S2CID   95218072.
  12. Centers for Disease Control Prevention (CDC) (August 2013). "Acetyl fentanyl overdose fatalities--Rhode Island, March-May 2013". MMWR. Morbidity and Mortality Weekly Report. 62 (34): 703–4. PMC   4604997 . PMID   23985500.
  13. Lozier MJ, Boyd M, Stanley C, Ogilvie L, King E, Martin C, Lewis L (June 2015). "Acetyl Fentanyl, a Novel Fentanyl Analog, Causes 14 Overdose Deaths in Rhode Island, March-May 2013". Journal of Medical Toxicology. 11 (2): 208–17. doi:10.1007/s13181-015-0477-9. PMC   4469714 . PMID   25934111.
  14. Drug Enforcement Administration (July 2015). "Acetyl fentanyl" (PDF). Drug Enforcement Administration Office of Diversion Control.
  15. Yonemitsu K, Sasao A, Mishima S, Ohtsu Y, Nishitani Y (October 2016). "A fatal poisoning case by intravenous injection of "bath salts" containing acetyl fentanyl and 4-methoxy PV8". Forensic Science International. 267: e6–e9. doi:10.1016/j.forsciint.2016.08.025. PMID   27591912.
  16. 关于印发《非药用类麻醉药品和精神药品列管办法》的通知 [Notice on Printing and Distributing the "Measures for the Scheduling of Non-Pharmaceutical Narcotic Drugs and Psychotropic Substances"]. sfda.gov.cn (in Chinese). 29 September 2015. Archived from the original on 1 October 2015. Retrieved 1 October 2015.
  17. "80 FR 29227 - Schedules of Controlled Substances: Temporary Placement of Acetyl Fentanyl into Schedule I". U.S. Government Publishing Office (GPO). 21 May 2015. Retrieved 30 June 2015.
  18. "Verordnung des EDI über die Verzeichnisse der Betäubungsmittel, psychotropen Stoffe, Vorläuferstoffe und Hilfschemikalien" [EDI ordinance on the lists of narcotics, psychotropic substances, precursors and auxiliary chemicals]. fedlex.admin.ch (in German). 30 May 2011.
  19. "The Misuse of Drugs Act 1971 (Modification) Order 1986". UK Home Office. 16 December 1986.
  20. Patton AL, Seely KA, Pulla S, Rusch NJ, Moran CL, Fantegrossi WE, et al. (February 2014). "Quantitative measurement of acetyl fentanyl and acetyl norfentanyl in human urine by LC-MS/MS". Analytical Chemistry. 86 (3): 1760–6. doi:10.1021/ac4036197. PMID   24354295.
  21. Baselt RC (2017). "Acetylfentanyl" (PDF). Disposition of toxic drugs and chemicals in man. Seal Beach, Ca.: Biomedical Publications. ISBN   978-0-692-77499-1.

Further reading